Phenobarbital for childhood epilepsy: Systematic review

Paediatric and Perinatal Drug Therapy

Volumn 7, Issue 1, 2006, Pages 31-42

  Pal, Deb K ^a  

^a Department of Medicine   (United States)

Author keywords

Adverse effects; Childhood; Efficacy; Epilepsy; Febrile convulsion; Phenobarbital; Randomised controlled trial; Systematic review

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; PHENOBARBITAL; PHENYTOIN; PLACEBO; VALPROIC ACID;

CHILDHOOD DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE DEFECT; DATA BASE; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPSY; FEBRILE CONVULSION; GENETICS; HUMAN; INFORMATION RETRIEVAL; MEDICAL LITERATURE; METHODOLOGY; MONOTHERAPY; OBSERVER BIAS; REVIEW; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; WESTERN HEMISPHERE;

EID: 47249163994     PISSN: 14630095     EISSN: None     Source Type: Journal    
DOI: 10.1185/146300905X75361     Document Type: Review

References (53)

1. Shorvon SD, Farmer PJ. Epilepsy in developing countries: a review of epidemiological, sociocultural and treatment aspects. Epilepsia 1988;29:36-54.
2. Shorvon SD. Drugs in developing countries (letter). BMJ 1986;292:1666-1667.
3. Newton RW. Randomised controlled trials of phenobarbitone and valproate in febrile convulsions. Arch Dis Child 1988;63:1189-1191.
4. de Silva M, Macardle B, McGowan M et al. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996;347:709-713.
5. Kwan P, Brodie MJ. Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 2004;45:1141-1149.
6. Hill P. Off licence and off label prescribing in children: litigation fears for physicians. Arch Dis Child 2005;90:i17-i18.
7. Juni P, Nartey L, Reichenbach S et al. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004;364:2021-2029.
8. French J, Smith M, Faught E, Brown L. Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 1999;52:1540-1545.
9. Lux AL, Edwards SW, Hancock E et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 2004;364:1773-1778.
10. Kale R, Perucca E. Revisiting phenobarbital for epilepsy. BMJ 2004;329:1199-1200.
11. Pal DK. Epilepsy control in the 21st century: leave no child behind. Epilepsia 2003;44:273-275.
12. Glenton C, Oxman AD. Cochrane Review Methodology. In: Available in: The Cochrane Library [database on disk and CDROM]. Oxford: Update Software; 1996.
13. Chalmers I, Altman DG. Systematic Reviews. London: BMJ Publishing Group; 1995.
14. Crawley J, Waruiru C, Mithwani S et al. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet 2000;355:701-706.
15. Coatsworth JJ. Studies on the clinical efficacy of marketed antiepileptic drugs. Washington, DC: Government Printing Office; 1971.
16. Verhagen AP, de Vet HC, de Bie RA et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998;51:1235-1241.
17. Thorn I. A controlled study of prophylactic long-term treatment of febrile convulsions with phenobarbital. Acta Neurol Scand Suppl 1975;60:67-73.
18. Heckmatt JZ, Houston AB, Clow DJ et al. Failure of phenobarbitone to prevent febrile convulsions. BMJ 1976;1:556-561.
19. Knudsen FU, Vestermark S. Prophylactic diazepam or phenobarbitone in febrile convulsions: a prospective, controlled study. Arch Dis Child 1978;53:660-663.
20. Wallace SJ, Smith JA. Successful prophylaxis against febrile convulsions with valproic acid or phenobarbitone. BMJ 1979;280:353-354.
21. Mackintosh TF. Studies on prophylactic treatment of febrile convulsions in children. Is it feasible to inhibit attacks by giving drugs at the first sign of fever or infection? Clin Pediatr 1970;9:283-286.
22. Farwell JR, Lee YJ, Hirtz DG et al. Phenobarbital for febrile seizures - effects on intelligence and on seizure recurrence. N Engl J Med 1990;322:364-369.
23. Wolf SM. The effectiveness of phenobarbital in the prevention of recurrent febrile convulsions in children with and without a history of pre-, peri-and postnatal abnormalities. Acta Paediatr Scand 1977;66:585-587.
24. Wolf SM, Forsythe A. Behavior disturbance, phenobarbital, and febrile seizures. Pediatrics 1978;61:728-731.
25. McKinlay I, Newton R. Intention to treat febrile convulsions with rectal diazepam, valproate or phenobarbitone. Dev Med Child Neurol 1989;31:617-625.
26. Bacon CJ, Hierons AM, Mucklow JC et al. Placebo-controlled study of phenobarbitone and phenytoin in the prophylaxis of febrile convulsions. Lancet 1981;2:600-604.
27. Garcia FO, Campos-Castello J, Maldonado JC. Fenobarbital oral continuado o diazepam rectal intermitente para la prevencion de las crisis febriles. Anales Espanoles de Pediatria 1984;20:763-769.
28. Wolf SM, Forsythe A, Stunden AA, Friedman R, Diamond H. Long-term effect of phenobarbital on cognitive function in children with febrile convulsions. Pediatrics 1981;68:820-823.
29. Camfield CS, Chaplin S, Doyle EB et al. Side effects of phenobarbital in toddlers; behavioral and cognitive aspects. J Pediatr 1979;95:361-365.
30. Camfield PR, Camfield CS, Shapiro SH, Cummings C. The first febrile seizure-antipyretic instruction plus either phenobarbital or placebo to prevent recurrence. J Pediatr 1980;97:16-21.
31. Ngwane E, Bower B. Continuous sodium valproate or phenobarbitone in the prevention of 'simple' febrile convulsions. Arch Dis Child 1980;55:171-174.
32. Lee K, Melchior JC. Sodium valproate versus phenobarbital in the prophylactic treatment of febrile convulsions in childhood. Eur J Pediatr 1981;137:151-153.
33. Anthony JH, Hawke SHB. Phenobarbital compared with carbamazepine in prevention of recurrent febrile convulsions. A double-blind study. Am J Dis Child 1983;137:892-895.
34. Mamelle N, Mamelle JC, Plasse JC, Revol M, Gilly R. Prevention of recurrent febrile convulsions, a randomised therapeutic assay: sodium valproate, phenobarbital and placebo. Neuropediatrics 1984;15:37-42.
35. Hirtz DG, Chen TC, Nelson KB et al. Does phenobarbital used for febrile seizures cause sleep disturbances? Pediatr Neurol 1993;9:94-100.
36. Ozdirim E, Renda Y. Epir S. Effects of phenobarbital and phenytoin on the behaviour of epileptic children. Advances in Epileptology 1978;13:120-123.
37. Chen YJ, Kang WM, So WC. Comparison of antiepileptic drugs on cognitive function in newly diagnosed epileptic children: a psychometric and neurophysiological study. Epilepsia 1996;37:81-86.
38. Young RSK, Alger PM, Bauer L, Lauderbaugh D. A randomized, double-blind, crossover study of phenobarbital and mephobarbital. J Child Neurol 1986;1:361-363.
39. Mitchell WG, Chavez JM. Carbamazepine versus phenobarbital for partial onset seizures in children. Epilepsia 1987;28:56-60.
40. Vining PG, Mellits ED, Dorsen MM et al. Psychologic and behavioural effects of antiepileptic drugs in children. a double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987;80:165-174.
41. Conners CK, Barkley RA. Rating scales and checklists for child psychopharmacology. Psychopharmacol Bull 1985;21:809-843.
42. Feksi AT, Kaamugisha J, Sander JWAS, Gatiti S, Shorvon SD. Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. Lancet 1991;337:406-409.
43. Placencia M, Sander JW, Shorvon SD et al. Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12 month assessment. Epilepsy Res 1993;14:237-244.
44. Pal DK, Das T, Chaudhury G, Johnson AL, Neville BGR. Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet 1998;351:19-23.
45. Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB. Analysis of clinical trials by treatment actually received: is it really an option? Stat Med 1991;10:1595-1605.
46. McConachie H. Implications of a model of stress and coping for services to families of young disabled children. Child Care Health Dev 1994;20:37-46.
47. Rutter M, Graham P, Yule WA. A neuropsychiatric study in childhood. Philadelphia: JB Lippincott, 1970.
48. Carlton-Ford S, Miller R, Brown M, Nealeigh N, Jennings P. Epilepsy and children's social and psychological adjustment. J Health Soc Behav 1995;36:285-301.
49. Pianta RC, Lothman DJ. Predicting behaviour problems in children with epilepsy: child factors, disease factors, family stress, and child-mother interaction. Child Dev 1994;65:1415-1428.
50. Pal DK, Das T, Chaudhury G, Sengupta S. Help-seeking patterns for epilepsy in rural India: implications for service delivery. Epilepsia 2002;43:904-911.
51. Tate SK, Depondt C, Sisodiya SM et al. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Proc Natl Acad Sci USA 2005;102:5507-5512.
52. Mamiya K, Hadama A, Yukawa E et al. CYP2C19 polymorphism effect on phenobarbitone. Pharmacokinetics in Japanese patients with epilepsy: analysis by population pharmacokinetics. Eur J Clin Pharmacol 2000;55:821-825.
53. Wolf SM, Carr A, Davis DC et al. The value of phenobarbital in the child who has had a single febrile seizure: a controlled perspective study. Pediatrics 1977;59:378-385.